Report Overview: The Global Structural Heart Devices Market achieved a valuation of $10.95 Billion in 2022 and is anticipated to exceed $22.64 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 9.5% during the forecast period from 2024 to 2032. Key Market Players: Medtronic plc; Braile Biomedica, St. Jude Medical, Inc., Medical Technology Est., Micro...